Jingying Cui

机构：Weifang People's Hospital

发表论文 7 篇 · 总被引 23 次 · h-index 2

代表论文

Reduced duration and dosage of venetoclax is efficient in newly diagnosed patients with acute myeloid leukemia (2023 · Hematology · 被引 17)
Postrelapse survival rate correlates with first‐line treatment strategy with thalidomide in patients with newly diagnosed multiple myeloma: a meta‐analysis (2011 · Hematological Oncology · 被引 4)
Real-World Effectiveness and Safety Analysis of Carfilzomib-Pomalidomide- Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Multicenter Retrospective Study from Eastern Shandong of China (2024 · Blood · 被引 1)
Reduced Duration and Dosage of Venetoclax Is Efficient in Newly Diagnosed Patients with Acute Myeloid Leukemia (2023 · Research Square · 被引 1)
Reduced duration and dosage of venetoclax is efficient in newly diagnosed patients with acute myeloid leukemia (2023 · Figshare)
Severity stratification of aplastic anemia (2014 · Chinese Medical Journal)